As part of the deal, the firm has bought a significant equity stake in the company from Avenue Capital Group.
Global Health operates a 900 bed hospital in Dehli, which is expected to expand to 1,300 beds.
The deal takes the total capital invested by Carlyle in India to $1.1bn.
Carlyle managing director Neeraj Bharadwaj said, “With an experienced management team, a best-in-class clinical team and infrastructure, Global Health has achieved a high distinctive positioning as a destination for complicated cases with a strong reputation in India.
“We see high growth potential in the healthcare industry in India driven by improving income profiles leading to higher hospitalization and treatment frequency. And the National Capital Region of Delhi, where Global Health is operating, has rapidly emerged as a healthcare hub.”
Earlier in 2013 it was reported that Carlyle was in talks to buy the domestic drug formulations business of Indian company Elder Pharmaceuticals.
Copyright © 2013 AltAssets